Literature DB >> 12634232

Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index.

U Mouritzen1, S Christgau, H-J Lehmann, L B Tankó, C Christiansen.   

Abstract

BACKGROUND: Cartilage normally has a slow turnover but in arthritis increased metabolism results in degradation of the tissue.
OBJECTIVE: To assess cartilage turnover in a sample of the general population by an assay measuring cartilage derived urinary collagen type II (CTX-II) C-telopeptide degradation products.
METHODS: CTX-II concentrations were measured in urine samples from 615 healthy men and women aged 20-87 years, and the influence of age, sex, menopause, hormone replacement therapy (HRT), and body mass index (BMI) was assessed.
RESULTS: CTX-II concentrations showed age dependent variations, with notable differences between men and women. Mean (SD) CTX-II concentration in postmenopausal women (220 (118) ng/mmol, n=25) was significantly higher than in an age matched group of premenopausal women (112 (79) ng/mmol, n=26, p<0.001). CTX-II concentration in women using HRT (118 (57) ng/mmol, n=50) was significantly lower than in an age and BMI matched group of women not receiving HRT (215 (99) ng/mmol, n=50, p<0.001). In subjects with a BMI >or=25 kg/m(2), CTX-II concentrations were significantly higher than in those with a BMI <25 kg/m(2) (185 (114) v 148 (91) ng/mmol, p<0.001).
CONCLUSIONS: Cartilage turnover, as assessed by measuring urinary degradation products of CTX-II varies considerably with age, and significant differences between CTX-II levels in men and women as well as in pre- and postmenopausal women are found. Further studies are required to validate the marker for assessing cartilage degradation in arthritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634232      PMCID: PMC1754496          DOI: 10.1136/ard.62.4.332

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

Review 1.  Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.

Authors:  P Garnero; J C Rousseau; P D Delmas
Journal:  Arthritis Rheum       Date:  2000-05

2.  Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers.

Authors:  E Vignon; P Garnero; P Delmas; B Avouac; P Bettica; M Boers; E Ehrich; N MacKillop; L Rovati; U Serni; T Spector; J Y Reginster
Journal:  Osteoarthritis Cartilage       Date:  2001-05       Impact factor: 6.576

3.  Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

Authors:  P Garnero; M Piperno; E Gineyts; S Christgau; P D Delmas; E Vignon
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

4.  Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.

Authors:  Patrick Garnero; Evelyne Gineyts; Stephan Christgau; Barbara Finck; Pierre D Delmas
Journal:  Arthritis Rheum       Date:  2002-01

5.  Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.

Authors:  C Rosenquist; C Fledelius; S Christgau; B J Pedersen; M Bonde; P Qvist; C Christiansen
Journal:  Clin Chem       Date:  1998-11       Impact factor: 8.327

6.  Collagen type II C-telopeptide fragments as an index of cartilage degradation.

Authors:  S Christgau; P Garnero; C Fledelius; C Moniz; M Ensig; E Gineyts; C Rosenquist; P Qvist
Journal:  Bone       Date:  2001-09       Impact factor: 4.398

Review 7.  The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

Authors:  P D Delmas; R Eastell; P Garnero; M J Seibel; J Stepan
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

Review 8.  Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages.

Authors:  S Boini; F Guillemin
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

9.  Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.

Authors:  R C Billinghurst; W Wu; M Ionescu; A Reiner; L Dahlberg; J Chen; H van Wart; A R Poole
Journal:  Arthritis Rheum       Date:  2000-03

Review 10.  The increasing impact of arthritis on public health.

Authors:  M J Elders
Journal:  J Rheumatol Suppl       Date:  2000-10
View more
  51 in total

1.  Whole blood lead levels are associated with biomarkers of joint tissue metabolism in African American and white men and women: the Johnston County Osteoarthritis Project.

Authors:  Amanda E Nelson; Sanjay Chaudhary; Virginia B Kraus; Fang Fang; Jiu-Chiuan Chen; Todd A Schwartz; Xiaoyan A Shi; Jordan B Renner; Thomas V Stabler; Charles G Helmick; Kathleen Caldwell; A Robin Poole; Joanne M Jordan
Journal:  Environ Res       Date:  2011-08-12       Impact factor: 6.498

2.  Serum markers of collagen metabolism: construction workers compared to sedentary workers.

Authors:  J I Kuiper; J H A M Verbeek; V Everts; J P Straub; M H W Frings-Dresen
Journal:  Occup Environ Med       Date:  2005-06       Impact factor: 4.402

3.  Closing the gap between bench and bedside research for early arthritis therapies (EARTH): report from the AOSSM/NIH U-13 Post-Joint Injury Osteoarthritis Conference II.

Authors:  Constance R Chu; Bruce D Beynnon; Joseph A Buckwalter; William E Garrett; Jeffrey N Katz; Scott A Rodeo; Kurt P Spindler; Robert A Stanton
Journal:  Am J Sports Med       Date:  2011-07       Impact factor: 6.202

Review 4.  Impact of treatments for osteoporosis on cartilage biomarkers in humans.

Authors:  P Richette; C Roux
Journal:  Osteoporos Int       Date:  2012-11-22       Impact factor: 4.507

Review 5.  Osteoarthritis and osteoporosis: what is the overlap?

Authors:  Irene E M Bultink; Willem F Lems
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

6.  Preventive effects of kudzu root on bone loss and cartilage degradation in ovariectomized rats [corrected].

Authors:  Yunyun Luo; Shuang Zheng; Yujia Ding; Yueqin Dai; Yi Zhou; Ruifeng Xiang; Anne C Bay-Jensen; Morten A Karsdal; Per Qvist; Qinlong Zheng
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

7.  Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study.

Authors:  I Meulenbelt; M Kloppenburg; H M Kroon; J J Houwing-Duistermaat; P Garnero; M-P Hellio Le Graverand; J Degroot; P E Slagboom
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

8.  The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover.

Authors:  Anne-Christine Bay-Jensen; Nadine C B Tabassi; Lene V Sondergaard; Thomas L Andersen; Frederik Dagnaes-Hansen; Patrick Garnero; Moustapha Kassem; Jean-Marie Delaissé
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156

Review 9.  New developments in osteoarthritis. Sex differences in magnetic resonance imaging-based biomarkers and in those of joint metabolism.

Authors:  Mehrnaz Maleki-Fischbach; Joanne M Jordan
Journal:  Arthritis Res Ther       Date:  2010-07-30       Impact factor: 5.156

10.  Collagen biomarkers for arthritis applications.

Authors:  James D Birmingham; Vladimir Vilim; Virginia B Kraus
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.